OCC

2.56%

40.0¢ orthocell limited

honestly occ has held up much better than the rest of my...

First 18 Last

Share
Profile

Follow
justchilln5

1,639 Posts.

441

10/09/23

05:33

Post #: 69799259
Share

Originally posted by bedger: ↑

Just a little weekend thought for all those investors losing faith in this company due to the share price - don't let the tail wag the dog.

OCC reported interest on its cash holdings alone of $850K:

Take a step back. That investors are selling a company that has $25 million in cash, is growing revenues (running at last reported $2.6 million yearly revenue rate) at 31.5% and forecast to go cash flow positive in CY 2025, well before that cash buffer gets pressed, for a mere $70 million, is frankly bonkers.That's purely on early global BioHorizons/Henry Schein Striate and Australian Remplir sales. Let alone going global on Remplir, following with CelGro tendon and rope, ACI, which turned Vericel in the US to a $1.6 billion mkt cap company, and of course about to report in days (at long bloody last) surgery vs ATI results, in an almost tandem study it did with a cortisone vs ATI study with Johnston and Johnston (even if you put a J&J partnership probability at 10% you'd surely double this mkt cap).

On existing business alone, OCC just announced a $645K sales quarter - that's a $2,580 million per year sales run rate in the last quarter. I would put 2024FY sales way above that and Veritas put their sales for 2024FY (BEFORE THIS EXCELLENT SALES RESULT) at $4.6 million (Veritas admittedly need to a little work on their recognition of the contract revenue for some objectivity and warning for investors using it as a tool).

I might die skint holding OCC in 20 years time. I think more likely I will own a small piece of a company that will have at least progressed to posting yearly revenues in the 100's of millions, possibly quarterly. Its no Amgen for the dreamers, but its ridiculous value at $70mill on existing known fundamentals and Thursday I bought more.

Expand

honestly occ has held up much better than the rest of my portfolio the last couple weeks…

OCC Price at posting: 35.5¢ Sentiment: Buy Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

As Nvidia cools, we're looking to Aussie AI

QML

Metallurgical testing shows saleable copper and pyrite from QMines' Develin Creek project

CBA breaks trading record on strong day for Aussie financials

OCC

Orthocell kicks off collagen-based dental bone repair product sales in Canada; eyeing next stop Brazil

SBW

Shekel Brainweigh investor presentation webinar – the future of retail automation

RMX

Red Mountain Mining: record gold prices, two projects, two greenstone belts

Week 36 Wrap: AI hype wave tested again; Oz per capita recession continues; AirTrunk’s $40B+ payday

PRU

Perseus Mining boosts stake in Predictive Discovery to 19.9% as latter's flagship project stalls

BIT

HotCopper users blunt as Biotron sinks -35%; long-awaited COVID drug results same as placebo

LAM

Laramide sniffs prime Kazakh uranium, with agreement over 6000 square km land position

There are more pages in this discussion • 1 more message in this thread...

First 18 Last

Add OCC (ASX) to my watchlist

(20min delay)
Last 40.0¢		Change 0.010(2.56%)		Mkt cap ! $83.83M

Open	High	Low	Value	Volume
39.0¢	40.0¢	39.0¢	$199.1K	504.6K

Buyers (Bids)

No.	Vol.	Price($)
1	3807	39.0¢

Sellers (Offers)

Price($)	Vol.	No.
40.0¢	3666	2

View Market Depth

No.	Vol.	Price($)
1	2599	0.385
3	27634	0.380
2	42700	0.375
4	23903	0.370
5	42071	0.365

Price($)	Vol.	No.
0.400	3666	2
0.405	74300	2
0.410	45237	4
0.420	135239	3
0.425	39350	3

Last trade - 16.10pm 06/09/2024 (20 minute delay)

OCC (ASX) Chart

honestly occ has held up much better than the rest of my...

As Nvidia cools, we're looking to Aussie AI

Metallurgical testing shows saleable copper and pyrite from QMines' Develin Creek project

CBA breaks trading record on strong day for Aussie financials

Orthocell kicks off collagen-based dental bone repair product sales in Canada; eyeing next stop Brazil

Shekel Brainweigh investor presentation webinar – the future of retail automation

Red Mountain Mining: record gold prices, two projects, two greenstone belts

Week 36 Wrap: AI hype wave tested again; Oz per capita recession continues; AirTrunk’s $40B+ payday

Perseus Mining boosts stake in Predictive Discovery to 19.9% as latter's flagship project stalls

HotCopper users blunt as Biotron sinks -35%; long-awaited COVID drug results same as placebo

Laramide sniffs prime Kazakh uranium, with agreement over 6000 square km land position

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

honestly occ has held up much better than the rest of my...

Top Stories

As Nvidia cools, we're looking to Aussie AI

Metallurgical testing shows saleable copper and pyrite from QMines' Develin Creek project

CBA breaks trading record on strong day for Aussie financials

Orthocell kicks off collagen-based dental bone repair product sales in Canada; eyeing next stop Brazil

Shekel Brainweigh investor presentation webinar – the future of retail automation

Red Mountain Mining: record gold prices, two projects, two greenstone belts

Week 36 Wrap: AI hype wave tested again; Oz per capita recession continues; AirTrunk’s $40B+ payday

Perseus Mining boosts stake in Predictive Discovery to 19.9% as latter's flagship project stalls

HotCopper users blunt as Biotron sinks -35%; long-awaited COVID drug results same as placebo

Laramide sniffs prime Kazakh uranium, with agreement over 6000 square km land position

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News